Posts
Ractigen Therapeutics Publishes Foundational Study on its Extrahepatic LiCO™ Delivery Platform in Molecular Therapy – Nucleic Acids
Source: PR Newswire · Ractigen Therapeutics · View original release Peer-reviewed study demonstrates potent, multi-month extrahepatic delivery via both systemic administration—targeting skeletal muscle, heart, and...
GoDaddy Brings ‘Ink Your Link’ Campaign to NYC: NYSE Content Update
Source: PR Newswire · New York Stock Exchange · View original release NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK,...
Shanghai, Hamburg seek closer ties as friendship turns 40
Source: PR Newswire · english.shanghai.gov.cn · View original releaseSHANGHAI, Oct. 23, 2026 /PRNewswire/ -- A news report from english.shanghai.gov.cn Peter Tschentscher (center), mayor of Hamburg, attends a...
Your weekly guide to Shanghai: Subscribe to our newsletter
Source: PR Newswire · english.shanghai.gov.cn · View original releaseSHANGHAI, Oct. 23, 2026 /PRNewswire/ -- A news report from english.shanghai.gov.cn Visit english.shanghai.gov.cn and click "Subscribe" at the...
Anycubic and Thingiverse Announce Exclusive Partnership to Expand Access to 3D Models
Source: PR Newswire · ANYCUBIC · View original releaseSHENZHEN, China, Oct. 23, 2026 /PRNewswire/ -- Anycubic, a global brand in 3D printing, announced an exclusive...
CSTS ENTERPRISES ESTABLISHES GLOBAL HEADQUARTERS IN NEW YORK CITY, ADVANCING GLOBAL GROWTH STRATEGY IN THE RISING EXPERIENCE ECONOMY
Source: PR Newswire · CSTS Enterprises · View original release NEW YORK, Oct. 23, 2026 /PRNewswire/ -- CSTS Enterprises ('CSTS' or the "Group"), an integrated...
AMTD IDEA’s Total Assets Exceeded US$2.6 Billion as of 2026 Half Year and Sets Forth Clear Growth Path in Global Hospitality
Source: PR Newswire · AMTD IDEA Group · View original release Revenue from contracts with customers grew by 32.1% to US$32.0 million Hospitality arm's revenue...
Vantage Enhances Its V-Card Premium Payment Experience for CFD Traders
Source: PR Newswire · Vantage · View original releaseV-Card combines everyday spending, applicable transaction fees and convenient card management. PORT VILA, Vanuatu, Oct. 23, 2026...
Zai Lab’s Zocilurtatug Pelitecan (Zoci, Formerly ZL-1310) Demonstrates High Response Rates, Encouraging Durability and Well-Tolerated Safety Profile in First-Line Extensive-Stage Small Cell Lung Cancer
Source: PR Newswire · Zai Lab · View original release- At the recommended Phase 3 dose (RP3D) of 1.6 mg/kg, zoci plus atezolizumab achieved a...